Effect of the Baseline Use of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin-Receptor Blockers (ARBs) on Outcomes of Patients With Suspected or Positive COVID-19 Infection

被引:0
|
作者
Muhlestein, Joseph B.
Knowlton, Kirk U.
May, Heidi T.
Knight, Stacey
Bair, Tami L.
Le, Viet T.
Horne, Benjamin D.
Anderson, Jeffrey L.
机构
关键词
D O I
10.1161/circ.142.suppl_3.16745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A16745
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Comparative Effectiveness of Angiotensin Receptor II Blockers (ARBs) vs. Angiotensin-Converting Enzyme Inhibitors (ACEIs) in Hypertensive Elderly Patients with Cardiovascular Comorbidities
    Setoguchi, Soko
    Shrank, William H.
    Liu, Jun
    Mogun, Helen
    Winkelmayer, Wolfgang C.
    Dreyer, Nancy A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S234 - S234
  • [42] Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
    Khalili, Azadeh
    Karim, Hosein
    Bayat, Gholamreza
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (04) : 312 - 316
  • [43] Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
    Jiuyang Xu
    Chaolin Huang
    Guohui Fan
    Zhibo Liu
    Lianhan Shang
    Fei Zhou
    Yeming Wang
    Jiapei Yu
    Luning Yang
    Ke Xie
    Zhisheng Huang
    Lixue Huang
    Xiaoying Gu
    Hui Li
    Yi Zhang
    Yimin Wang
    Frederick G. Hayden
    Peter W. Horby
    Bin Cao
    Chen Wang
    Frontiers of Medicine, 2020, 14 : 601 - 612
  • [44] Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
    Xu, Jiuyang
    Huang, Chaolin
    Fan, Guohui
    Liu, Zhibo
    Shang, Lianhan
    Zhou, Fei
    Wang, Yeming
    Yu, Jiapei
    Yang, Luning
    Xie, Ke
    Huang, Zhisheng
    Huang, Lixue
    Gu, Xiaoying
    Li, Hui
    Zhang, Yi
    Wang, Yimin
    Hayden, Frederick G.
    Horby, Peter W.
    Cao, Bin
    Wang, Chen
    FRONTIERS OF MEDICINE, 2020, 14 (05) : 601 - 612
  • [45] Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis
    Sadria, Mehrshad
    Layton, Anita T.
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [46] Re: Is there a difference in the effect between the angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker on the COVID-19?
    Liu, Xiao
    Long, Chuyan
    Xiong, Qinmei
    Chen, Chen
    Ma, Jianyong
    Su, Yuhao
    Hong, Kui
    CLINICAL CARDIOLOGY, 2021, 44 (01) : 7 - 8
  • [47] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIS) OR ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): A META-ANALYSIS
    Bhat, Vivek
    Kumar, Ashish
    Kalra, Ankur
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 780 - 780
  • [48] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
    Cure, Erkan
    Cure, Medine Cumhur
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 349 - 350
  • [49] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [50] Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19
    Khera, Rohan
    Clark, Callahan
    Lu, Yuan
    Guo, Yinglong
    Ren, Sheng
    Truax, Brandon
    Spatz, Erica S.
    Murugiah, Karthik
    Lin, Zhenqiu
    Omer, Saad B.
    Vojta, Deneen
    Krumholz, Harlan M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (13):